Harmony Biosciences Holdings (HRMY) Change in Inventory (2019 - 2026)

Harmony Biosciences Holdings has disclosed Change in Inventory across 8 years of filings, most recently posting -$76000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at -$76000.0, up 90.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 309.3% YoY), and the FY2025 annual result was -$1.8 million, down 200.33% from the prior year.
• Change in Inventory came in at -$76000.0 for Q1 2026 at Harmony Biosciences Holdings, up from -$1.5 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $1.3 million in Q3 2024 to a low of -$1.5 million in Q4 2025.
• The 5-year median for Change in Inventory is $165000.0 (2022), against an average of $49941.2.
• Across the five-year window, Change in Inventory soared 445.92% in 2024 and slumped 638.87% in 2025, its largest moves.
• Harmony Biosciences Holdings' Change in Inventory stood at $397000.0 in 2022, then slumped by 30.48% to $276000.0 in 2023, then climbed by 2.54% to $283000.0 in 2024, then plunged by 638.87% to -$1.5 million in 2025, then jumped by 95.02% to -$76000.0 in 2026.
• The last three Change in Inventory figures came in at -$76000.0 (Q1 2026), -$1.5 million (Q4 2025), and $782000.0 (Q3 2025), per Business Quant data.